Portfolio Health Check
| Score Your rating score is 3.27 / 5.0 | Breakdown Strong Buy: 0 stocks Buy: 3 stocks Hold: 22 stocks Sell: 1 stock Strong Sell: 0 stocks |
Yesterday's Performance
| Top Gainers | Top Losers |
| HWM: +1.18% | AA: -3.15% |
| XOM: +0.99% | PSX: -2.16% |
| CVX: +0.46% | DD: -1.93% |
Breaking News
FEATURED: Be a better investor with Premium
Research shows that individual investors collectively underperform the market, because their decisions are often driven by emotions. Stay ahead of the curve with Seeking Alpha Premium's in-depth analysis and data-driven stock ratings.
Analysis
| 3M: Near-Term Growth Looks Limited, But A Fresh Start Is Welcome (Upgrade) Stephen Simpson • MMM |
| Bristol-Myers Squibb Is A Bargain Now Daniel Schönberger • BMY |
| Anticipating AT&T's Q2 Comeback Yiannis Zourmpanos • T |
Related Analysis
| Betting The Farm - These 6 Dividend Stocks Dominate Our Family's Portfolios Leo Nelissen • RTX |
| Don't Overthink It - Bet On Safety And Predictability Brad Thomas • JNJ • CVX |
| Is It Worth Picking Individual Large Cap Value Stocks? My H1 Performance Says No Charles Argon • RTX |
| ClearBridge Select Strategy Q2 2024 Commentary ClearBridge Investments • XOM |
| Oakmark Global Fund: Q2 2024 Quarterly Commentary Harris Oakmark • DE |
| Building A $100,000 Dividend Portfolio With Optimized Risk-Reward Profile Frederik Mueller • T • JNJ • XOM |
| The Dividends Don't Matter, Except They Do Robert & Sam Kovacs • T • PFE |
| Cannabis Investing In The Age Of Legalization With Julian Lin, Tim Seymour And Pablo Zuanic The Cannabis Investing Podcast • KO |
If you believe this has been sent to you in error, please safely unsubscribe.
